Drugs that Target Cellular Signaling Pathways for Breast Cancer Treatment
Current Practice in Medical Science Vol. 6,
14 July 2022
The identification of genetic mutations and the exploration of several cellular signaling pathways has led to the development of a number of molecular targeting agents, which can be targeted in several ailments for therapeutic basis. Recently, many drugs have been introduced to treat breast cancer. These drugs are administered either orally or via an injection. These drug delivery systems minimize toxicity and improve efficiency. These new drugs and delivery mechanisms have replaced the older cumbersome strategies and have helped the patients in several ways. They offer greater benefits to patients and have reduced side effects.
- Cellular signaling
- breast cancer treatment
- genetic mutations